Zobrazeno 1 - 10
of 1 789
pro vyhledávání: '"Chemotherapy response"'
Autor:
Ping’an Ding, Jiaxuan Yang, Jiaxiang Wu, Haotian Wu, Chenyu Sun, Shuya Chen, Peigang Yang, Yuan Tian, Honghai Guo, Yang Liu, Lingjiao Meng, Qun Zhao
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background The prognosis nutritional index (PNI) and the systemic inflammatory immunological index (SII) are characteristic indicators of the nutritional state and the systemic inflammatory response, respectively. However, there is an unknow
Externí odkaz:
https://doaj.org/article/d1b36a569ab54ec8b748501aadc3e568
Publikováno v:
Journal of Ovarian Research, Vol 17, Iss 1, Pp 1-12 (2024)
Abstract Objective This study evaluates the potential superiority of combining paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) with sequential intravenous neoadjuvant chemotherapy over intravenous neoadjuvant chemotherapy alone in
Externí odkaz:
https://doaj.org/article/ce513aa0d5f74a0db99f46f847c136f3
Autor:
Ali Ajrouch, Ben Krempley, Ahmad Karkash, John M. Dewitt, Mohammad Al-Haddad, Dawith Lim, David Nolte, John Turek, Susan M. Perkins, Shadia I. Jalal
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundEsophageal cancer management lacks reliable response predictors to chemotherapy. In this study we evaluated the feasibility and accuracy of Biodynamic Imaging (BDI), a technology that employs digital holography as a rapid predictor of chemo
Externí odkaz:
https://doaj.org/article/14148048c0b14ed4baac64313345ad62
Autor:
Philip Prathipati, Anup S. Pathania, Nagendra K. Chaturvedi, Subash C. Gupta, Siddappa N. Byrareddy, Don W. Coulter, Kishore B. Challagundla
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 35, Iss 2, Pp 101543- (2024)
Neuroblastoma is the most devastating extracranial solid malignancy in children. Despite an intense treatment regimen, the prognosis for high-risk neuroblastoma patients remains poor, with less than 40% survival. So far, MYCN amplification status is
Externí odkaz:
https://doaj.org/article/7d9eb9261b3e4d0b860be7a5cf90ac13
Autor:
Zhen Liu, Liangwang Yang, Wenqi Wu, Zejun Chen, Zhengxing Xie, Daoming Shi, Ning Cai, Shenghua Zhuo
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
BackgroundGlioma is the most common cancer of the central nervous system with poor therapeutic response and clinical prognosis. Insulin-like growth factor 1 receptor (IGF-1R) signaling is implicated in tumor development and progression and induces ap
Externí odkaz:
https://doaj.org/article/0c0b410219974a97a042449fc5983146
Autor:
Anum S. Kazerouni, Lanell M. Peterson, Isaac Jenkins, Alena Novakova-Jiresova, Hannah M. Linden, Julie R. Gralow, David M. Hockenbery, David A. Mankoff, Peggy L. Porter, Savannah C. Partridge, Jennifer M. Specht
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Purpose To investigate combined MRI and 18F-FDG PET for assessing breast tumor metabolism/perfusion mismatch and predicting pathological response and recurrence-free survival (RFS) in women treated for breast cancer. Methods Patients undergo
Externí odkaz:
https://doaj.org/article/39009f83429149d1a6767eb32e70cc5b
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Radio/chemotherapy and immune systems provide examples of hormesis, as tumours can be stimulated (or reduced) at low radio/chemical or antibody doses but inhibited (or stimulated) by high doses. Methods Interactions between effect
Externí odkaz:
https://doaj.org/article/05f1a182207d4db9ac2544470d8a9981
Autor:
Sumit Sahni, Christopher Nahm, Mahsa S. Ahadi, Loretta Sioson, Sooin Byeon, Angela Chou, Sarah Maloney, Elizabeth Moon, Nick Pavlakis, Anthony J. Gill, Jaswinder Samra, Anubhav Mittal
Publikováno v:
Cancer Medicine, Vol 12, Iss 17, Pp 18050-18061 (2023)
Abstract Aim Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all major cancers. Chemotherapy is the mainstay systemic therapy for PDAC, and chemoresistance is a major clinical problem leading to therapeutic failure. This study
Externí odkaz:
https://doaj.org/article/e90fdec124084c0493ac5c88c8aabda8
Autor:
Prihantono, MD–PhD, Muhammad Faruk, MD
Publikováno v:
Surgery Open Science, Vol 15, Iss , Pp 19-25 (2023)
Background: Breast cancer is the most common malignancy among women worldwide. Previous studies have shown factors influencing breast cancer patients' survival, including histopathological grading, stage, histopathological type, hormone receptors, an
Externí odkaz:
https://doaj.org/article/b858fed0d69a4f9a9d835d0ef5328976
Publikováno v:
Pharmaceuticals, Vol 17, Iss 5, p 604 (2024)
The involvement of the gut microbiota in anti-cancer treatment has gained increasing attention. Alterations to the structure and function of the gut bacteria are important factors in the development of cancer as well as the efficacy of chemotherapy.
Externí odkaz:
https://doaj.org/article/313ac48911d740bda5616805b268f467